Inventor · disambiguated record
Mark E. Hayes
Also filed as: HAYES MARK E · HAYES MARK EAMON
16 granted patents·24 pending applications·105 citations·filing 2003–2025
93Inventor score
Files withIPSEN BIOPHARM LTD11ZONEONE PHARMA INC11AKAGERA MEDICINES INC6CELATOR PHARMACEUTICALS INC3HAYES MARK E2
Top patents by PatentIndex Score
40 records- 0197US12077725B2Ionizable cationic lipidsAKAGERA MEDICINES INC·Filed 2022·Granted Sep 3, 2024·4 cites·20 claims
- 0297US11591544B2Ionizable cationic lipidsAKAGERA MEDICINES INC·Filed 2021·Granted Feb 28, 2023·7 cites·16 claims
- 0397US10087464B2Compositions and methods for delivering nucleic acid to a cellMERRIMACK PHARMACEUTICALS INC·Filed 2016·Granted Oct 2, 2018·16 cites·6 claims
- 0496US12064479B2Lipid nanoparticles for delivery of nucleic acids and methods of use thereofAKAGERA MEDICINES INC·Filed 2023·Granted Aug 20, 2024·5 cites·28 claims
- 0594US9737485B2Remote loading of sparingly water-soluble drugs into liposomesZONEONE PHARMA INC·Filed 2016·Granted Aug 22, 2017·8 cites·17 claims
- 0693US10993914B2Stabilizing camptothecin pharmaceutical compositionsIPSEN BIOPHARM LTD·Filed 2019·Granted May 4, 2021·10 cites·36 claims
- 0793US10456360B2Stabilizing camptothecin pharmaceutical compositionsIPSEN BIOPHARM LTD·Filed 2016·Granted Oct 29, 2019·19 cites·31 claims
- 0891US12331264B2Lipid nanoparticles for delivery of nucleic acids and methods of use thereofAKAGERA MEDICINES INC·Filed 2022·Granted Jun 17, 2025·1 cites·20 claims
- 0989US10507182B2Remote loading of sparingly water-soluble drugs into liposomesZONEONE PHARMA INC·Filed 2018·Granted Dec 17, 2019·2 cites·20 claims
- 1089US8883200B2Delivery of nucleic acid-like compoundsSutter West Bay Hospital·Filed 2013·Granted Nov 11, 2014·8 cites·24 claims
- 1188US8496961B2Delivery of nucleic acid-like compoundsHONG KEELUNG·Filed 2003·Granted Jul 30, 2013·20 cites·2 claims
- 1287US10004759B2Remote loading of sparingly water-soluble drugs into lipid vesiclesZONEONE PHARMA INC·Filed 2015·Granted Jun 26, 2018·2 cites·16 claims
- 1386US11583544B2Remote loading of sparingly water-soluble drugs into lipid vesiclesCELATOR PHARMACEUTICALS INC·Filed 2019·Granted Feb 21, 2023·1 cites·18 claims
- 1486US2025152578A1Stabilizing Camptothecin Pharmaceutical CompositionsIPSEN BIOPHARM LTD·Filed 2024·Application pending·0 cites
- 1586US2024424007A1Remote loading of sparingly water-soluble drugs into lipid vesiclesCELATOR PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1685US12059497B2Stabilizing camptothecin pharmaceutical compositionsIPSEN BIOPHARM LTD·Filed 2021·Granted Aug 13, 2024·1 cites·51 claims
- 1785US10722467B2Remote loading of sparingly water-soluble drugs into liposomesZONEONE PHARMA INC·Filed 2019·Granted Jul 28, 2020·1 cites·10 claims
- 1884US12070471B2Remote loading of sparingly water-soluble drugs into lipid vesiclesCELATOR PHARMACEUTICALS INC·Filed 2023·Granted Aug 27, 2024·0 cites·15 claims
- 1982US2024325525A1Lipid Nanoparticles for Delivery of Nucleic Acids and Methods of Use ThereofAKAGERA MEDICINES INC·Filed 2024·Application pending·0 cites
- 2081US2025000796A1Stabilizing Camptothecin Pharmaceutical CompositionsIPSEN BIOPHARM LTD·Filed 2024·Application pending·0 cites
- 2179US2023108934A1Stabilizing Camptothecin Pharmaceutical CompositionsIPSEN BIOPHARM LTD·Filed 2022·Application pending·0 cites
- 2275US2009171077A1Delivery of nucleic acid-like compoundsCALIFORNIA PACIFIC MED CENTER·Filed 2009·Application pending·0 cites
- 2373US2020179371A1Stabilizing Camptothecin Pharmaceutical CompositionsIPSEN BIOPHARM LTD·Filed 2019·Application pending·0 cites
- 2472US2015140069A1Delivery of nucleic acid-like compoundsSUTTER WEST BAY HOSPITAL DBA CALIFORNIA PACIFIC MEDICAL CT·Filed 2014·Application pending·0 cites
- 2570US2014220111A1Remote loading of sparingly water-soluble drugs into liposomesZONEONE PHARMA INC·Filed 2014·Application pending·0 cites
- 2670US2021228567A1Stabilizing Camptothecin Pharmaceutical CompositionsIPSEN BIOPHARM LTD·Filed 2020·Application pending·0 cites
- 2769US2019105339A1Remote loading of sparingly water-soluble drugs into lipid vesiclesZONEONE PHARMA INC·Filed 2018·Application pending·0 cites
- 2868US2019262331A9Stabilizing Camptothecin Pharmaceutical CompositionsIPSEN BIOPHARM LTD·Filed 2018·Application pending·0 cites
- 2966US2017202776A1Remote loading of sparingly water-soluble drugs into liposomesZONEONE PHARMA INC·Filed 2017·Application pending·0 cites
- 3063US2019017073A1Compositions and methods for delivering nucleic acid to a cellMERRIMACK PHARMACEUTICALS·Filed 2018·Application pending·0 cites
- 3163US2014220110A1Remote loading of sparingly water-soluble drugs into liposomesZONEONE PHARMA INC·Filed 2014·Application pending·0 cites
- 3261US2014271825A1Pharmaceutical formulations of chelating agents as a metal removal treatment systemZONEONE PHARMA INC·Filed 2014·Application pending·0 cites
- 3357US2014065204A1Compositions and methods for delivering nucleic acid to a cellMERRIMACK PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 3456US2025387462A1Lipid nanoparticles for delivery of nucleic acids and vaccine for the prevention of tuberculosis or other mycobacterial infectionsAKAGERA MEDICINES INC·Filed 2025·Application pending·0 cites
- 3554US2017128366A1Pharmaceutical formulations of chelating agents as a metal removal treatment systemZONEONE PHARMA INC·Filed 2017·Application pending·0 cites
- 3652US2014220112A1Transformation of drug cyclodextrin complex compositions into compositions of mixtures of lipid vesicle encapsulated drug and cyclodextrin drug complexesZONEONE PHARMA INC·Filed 2014·Application pending·0 cites
- 3750US2017319573A1Stabilizing Camptothecin Pharmaceutical CompositionsIPSEN BIOPHARM LTD·Filed 2017·Application pending·0 cites
- 3841US2017231910A1Pharmaceutical formulations of chelating agents as a metal removal treatment systemHAYES MARK E·Filed 2015·Application pending·0 cites
- 3941US2017239182A1Pharmaceutical formulations of and methods to prepare chelating agents for efficient metal removal treatment systemsHAYES MARK E·Filed 2015·Application pending·0 cites
- 4036US2018110771A1Liposomal Irinotecan PreparationsIPSEN BIOPHARM LTD·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark E. Hayes files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →